rs200042949
Variant summary
Our verdict is Benign. The variant received -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2
The NM_015631.6(TCTN3):c.946A>G(p.Thr316Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00114 in 1,551,524 control chromosomes in the GnomAD database, including 3 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_015631.6 missense
Scores
Clinical Significance
Conservation
Publications
- ciliopathyInheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
- orofaciodigital syndrome IVInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, Labcorp Genetics (formerly Invitae), Orphanet, Laboratory for Molecular Medicine
- Joubert syndrome 18Inheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
- Meckel syndromeInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- orofaciodigital syndrome type 6Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -13 ACMG points.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| TCTN3 | ENST00000371217.10 | c.946A>G | p.Thr316Ala | missense_variant | Exon 8 of 14 | 1 | NM_015631.6 | ENSP00000360261.5 | ||
| TCTN3 | ENST00000265993.13 | c.1000A>G | p.Thr334Ala | missense_variant | Exon 8 of 14 | 1 | ENSP00000265993.9 | |||
| TCTN3 | ENST00000430368.6 | c.651+916A>G | intron_variant | Intron 5 of 9 | 2 | ENSP00000387567.1 |
Frequencies
GnomAD3 genomes AF: 0.00113 AC: 172AN: 152208Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.000825 AC: 129AN: 156422 AF XY: 0.000748 show subpopulations
GnomAD4 exome AF: 0.00114 AC: 1599AN: 1399198Hom.: 3 Cov.: 30 AF XY: 0.00116 AC XY: 799AN XY: 690096 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.00113 AC: 172AN: 152326Hom.: 0 Cov.: 32 AF XY: 0.00118 AC XY: 88AN XY: 74498 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
not provided Uncertain:2Benign:3
In silico analysis supports that this missense variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge; This variant is associated with the following publications: (PMID: 26582918) -
- -
- -
TCTN3: BP4 -
- -
Orofacial-digital syndrome IV;C3553758:Joubert syndrome 18 Uncertain:1Benign:1
- -
- -
not specified Uncertain:1
DNA sequence analysis of the TCTN3 gene demonstrated a sequence change, c.946A>G, in exon 8 that results in an amino acid change, p.Thr316Ala. This sequence change has been described in the gnomAD database with a frequency of 0.20% in the non-Finnish European subpopulation (dbSNP rs200042949). The p.Thr316Ala change affects a moderately conserved amino acid residue located in a domain of the TCTN3 protein that is known to be functional. The p.Thr316Ala substitution appears to be benign using several in-silico pathogenicity prediction tools (SIFT, PolyPhen2, Align GVGD, REVEL). This sequence change does not appear to have been previously described in individuals with TCTN3-related disorders. Due to insufficient evidences and the lack of functional studies, the clinical significance of the p.Thr316Ala change remains unknown at this time. -
TCTN3-related disorder Benign:1
This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at